TLRY Tilray

Good Supply Cannabis Brand Launches Canada’s Strongest Infused Pre-Rolls

Good Supply Cannabis Brand Launches Canada’s Strongest Infused Pre-Rolls

Introducing the New Good Supply MONSTERS™ Pre-Rolls Now Available Across Canada

TORONTO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company today announced further portfolio expansion of their best-selling Canadian cannabis brand Good Supply1, with the launch of their latest innovation of ‘MONSTERS’ infused pre-rolls.

The Good Supply MONSTERS pre-rolls are made from a combination of two of our most potent signature strains frankensteined into a jaw-dropping pre-roll, coming in at a whopping 2.38g and 42.0% THC (420mg/g). Being the first of its kind, “MONSTERS” have been officially trademarked, differentiating its offerings from other infused pre-rolls products in the Canadian market; they feature a unique formulation of strain-specific milled flower infused with strain-specific BHO, and are coated in extract and dipped in kief to achieve a wicked 1,000mg of THC – the most THC allowed in one package2 – making them Canada’s strongest infused pre-rolls.

Good Supply MONSTERS pre-rolls are now on the loose in two unique options, including:

  • Golden Guy (Sativa) infused pre-roll: A thrilling twist of Jean Guy milled flower and Golden Goat BHO
  • Monkey Walker (Indica) infused pre-roll: A monster mashup of Monkey Butter milled flower and Starwalker Kush BHO

Along with the maximum allowable content of 1,000mg THC, these monstrous pre-rolls have been developed to deliver a smooth smoking experience, utilizing an XL Filter and an extract coating for an improved burn and smooth smoke. As one of Canada’s leading cannabis brands, Good Supply seeks to deliver feel good highs and provide a range of cannabis experiences for consumers to discover. Good Supply MONSTERS pre-rolls were designed for highly experienced cannabis users looking for the most of what a pre-roll can offer.

Good Supply’s MONSTERS pre-rolls are now available at select retailers across Alberta, Manitoba, Saskatchewan, and Ontario with further anticipated expansion across Canada.

                                        

1
Produced in accordance with Health Canada Processing and Cultivation licence by Aphria Inc., a subsidiary of Tilray Brands, Inc.

2
 “The most THC allowed in one package” – Health Canada, proposed regulations for additional cannabis products available at:

About Good Supply

Good Supply is one of Canada's leading cannabis brands in flower, pre-rolls, vapes, concentrates, and has become a favourite among consumers and budtenders. At Good Supply good is the new great. Rooted in classic strains that punch above their weight, Good Supply has been one of the top-selling brands in the concentrates and pre-roll category within Canada and is known for its innovative take on its products across its expansive portfolio.

To learn more about Good Supply, visit  and follow @goodsupplycannabis.

About Tilray Brands

 Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information on Tilray, visit  and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ability to commercialize new and innovative products worldwide. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

Contacts:

Media:

Kaitlin Macapagal

Investors

Raphael Gross

203-682-8253



EN
22/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Request...

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including...

 PRESS RELEASE

Tilray Medical stringe una partnership strategica in Italia per render...

Tilray Medical stringe una partnership strategica in Italia per rendere più accessibili gli estratti di cannabis terapeutica FL Group, società di Tilray, collabora con Molteni, una grande azienda farmaceutica che si occupa di terapie del dolore e per il trattamento della dipendenza da sostanze NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis terapeutica, impegnata a rafforzare l'alleanza terapeutica tra pazienti e operatori sanitari per consentire decisioni s...

 PRESS RELEASE

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access ...

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, announced today that its wholly-owned subsidiary, FL Group S.R.L., has...

 PRESS RELEASE

Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drin...

Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane’s and Happy Flower Brands NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- . (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: and . Fizzy Jane’s, the sparkling seltzer line that debuted this spring in Georgia, North Carolina, and South Carolina, is now available in a 10mg HDD9 THC format, enhancing the buzz while keeping the same crisp, fruit-forward refreshment fans love. With 15...

 PRESS RELEASE

Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at...

Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at Whole Foods Market The Humble Seed Introduces the Ultimate Protein Snack and Better-for-You Crackers with 5g of Superseed Protein NEW YORK and WINNIPEG, Manitoba, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Humble Seed, a better-for-you snack brand from Tilray Wellness a subsidiary of Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY; TSX: TLRY), today announced the launch of its new featuring 5g of plant-based protein per serving. Available in three crave-worthy flavors—Sea Salt, Garlic Herb, and Rosemary Sea Salt—this innova...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch